NCT02016196 - Rifaximin vs Placebo for the Prevention of Encephalopathy in Patients Treated by TIPS | Biotech Hunter

Enrollment

211

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions

Cirrhosis

Interventions

DRUG

Rifaximin

"6 rifaximin caps of 200 mg morning and night, 15 days before and 6 months after TIPS~\--------------------------------------------------------------------------------"

DRUG

placebo

6 placebo caps per day morning and night, during 15 days before TIPS and 6 months after TIPS

Trial Locations (13)

31059

UHToulouse, Toulouse

Unknown

CHU Angers, Angers

Hôpital Jean Verdier, Bondy

CHU Bordeaux, Bordeaux

CHRU Lille, Lille

CHU Marseille, Marseille

CHU Nantes, Nantes

CHU Beaujon Clichy, Paris

CHU Saint-Antoine, Paris

Pitié Salpêtrière, Paris

CHU Poitiers, Poitiers

CHU Rennes, Rennes

CHU Tours, Tours

All Listed Sponsors

lead

University Hospital, Toulouse

OTHER